Dr. Concepcion Vicenta Llorente Cortes | Biomedical | Best Researcher Award

Dr. Concepcion Vicenta Llorente Cortes | Biomedical | Best Researcher Award

Doctorate at Consejo Superior de Investigaciones Científicas, Spain

👨‍🎓 Profiles

Scopus

Orcid

Publications

PCSK9 Antibodies Treatment Specifically Enhances the Macrophage-specific Reverse Cholesterol Transport Pathway in Heterozygous Familial Hypercholesterolemia

  • Authors: Borràs, C., Canyelles, M., Girona, J., Blanco-Vaca, F., Escolà-Gil, J.C.
  • Journal: JACC: Basic to Translational Science
  • Year: 2024

sICAM-1 concentrations are associated with inflammation in contralateral carotid plaque in patients with ischemic stroke

  • Authors: Puig, N., Camps-Renom, P., Garcia, E., Llorente-Cortés, V., Benitez, S.
  • Journal: Clinica e Investigacion en Arteriosclerosis
  • Year: 2024

Mechanisms modulating foam cell formation in the arterial intima: exploring new therapeutic opportunities in atherosclerosis

  • Authors: La Chica Lhoëst, M.T., Martinez, A., Claudi, L., Escolà-Gil, J.C., Llorente-Cortés, V.
  • Journal: Frontiers in Cardiovascular Medicine
  • Year: 2024

Transcriptional analysis reveals that the intracellular lipid accumulation impairs gene expression profiles involved in insulin response-associated cardiac functionality

  • Authors: Actis Dato, V., Paz, M.C., Rey, F.E., Chiabrando, G.A., Ceschin, D.G.
  • Journal: Scientific Reports
  • Year: 2023

Soluble low-density lipoprotein receptor-related protein 1 as a surrogate marker of carotid plaque inflammation assessed by 18F-FDG PET in patients with a recent ischemic stroke

  • Authors: Garcia, E., Camps-Renom, P., Puig, N., Benitez, S., Llorente-Cortés, V.
  • Journal: Journal of Translational Medicine
  • Year: 2023

Prof. Anna Pannaccione | Biomedical | Best Researcher Award

Prof. Anna Pannaccione | Biomedical | Best Researcher Award

Professor at Federico II University of Naples, Italy

Profiles

Scopus

Orcid

Summary:

Prof. Anna Pannaccione has been an Associate Professor in Pharmacology since 2019, specializing in neurodegeneration research, particularly in Alzheimer’s Disease (AD) and Parkinson’s Disease (PD). Her work focuses on the dysregulation of ionic homeostasis, especially ion channels and exchangers, employing electrophysiological techniques. With 68 peer-reviewed publications and three patents, she is actively engaged in multidisciplinary research collaborations both nationally and internationally.

Education

Prof. Pannaccione completed her doctoral studies in Pharmacology, focusing on the molecular mechanisms underlying neurodegenerative diseases.

💼 Professional Experience

Prof. Pannaccione’s academic career is dedicated to discovering innovative therapies for neurodegenerative diseases like AD and PD. Her research emphasizes modulating Kv3.4 function, with the goal of developing therapeutic strategies to address energy failure and firing instability in neurodegenerative conditions.

🔬 Research Interests

Her research encompasses life sciences, focusing on neurological and neurodegenerative disorders, and the repair and regeneration of the nervous system. She is also a member of various research commissions, including SINS, SIF, and SfN, and serves as a referee for numerous international peer-reviewed journals.

 

Publications

Ultrafine particulate matter pollution and dysfunction of endoplasmic reticulum Ca2+ store: A pathomechanism shared with amyotrophic lateral sclerosis motor neurons?

  • Authors: Sapienza, S., Tedeschi, V., Apicella, B., Loffredo, S., Secondo, A.
  • Journal: Ecotoxicology and Environmental Safety
  • Year: 2024
  • Authors: Cantone, A.F., Burgaletto, C., Di Benedetto, G., Bernardini, R., Cantarella, G.
  • Journal: Cells
  • Year: 2024

Expanding Structure-Activity Relationships of Human Urotensin II Peptide Analogues: A Proposed Key Role of the N-Terminal Region for Novel Urotensin II Receptor Modulators

  • Authors: Merlino, F., Secondo, A., Mitidieri, E., d’Emmanuele di Villa Bianca, R., Carotenuto, A.
  • Journal: Journal of Medicinal Chemistry
  • Year: 2024

The 3-(3-oxoisoindolin-1-yl)pentane-2,4-dione (ISOAC1) as a new molecule able to inhibit Amyloid β aggregation and neurotoxicity

  • Authors: Piccialli, I., Greco, F., Roviello, G., Massa, A., Pannaccione, A.
  • Journal: Biomedicine and Pharmacotherapy
  • Year: 2023

Na+/Ca2+ exchanger isoform 1 takes part to the Ca2+-related prosurvival pathway of SOD1 in primary motor neurons exposed to beta-methylamino-l-alanine

  • Authors: Petrozziello, T., Boscia, F., Tedeschi, V., Annunziato, L., Secondo, A.
  • Journal: Cell Communication and Signaling
  • Year: 2022

Ms. Shreya Agarwal | Biomedical | Best Researcher Award

Ms. Shreya Agarwal | Biomedical | Best Researcher Award

Shreya Agarwal at University of Freiburg, Germany

Profiles

Google Scholar

Academic Background

Ms. Shreya Agarwal is a dedicated Life Scientist with a Master’s in Neuroscience and a passion for advancing our understanding of the brain. With substantial experience in laboratory research, she excels in data analysis, microscopy, molecular biology, and genetics. Known for her strong organizational skills and ability to manage multiple projects with precision, Shreya is committed to contributing to her team’s success and taking on new challenges.

Education

Master of Science (M.Sc.) in Molecular and Translational Neurosciences
University of Ulm, Germany (2021)
Thesis: “Study of the mutation KIF5A in ALS, which promotes protein aggregation”

Bachelor of Science (B.Sc.) in Neurosciences
Amity University, Noida, India (2019)
Thesis: “The role of chronic hypobaric hypoxia in the development of cognitive impairment”

Work Experience

PhD Student, Biomikrotechnik
Institut für Mikrosystemtechnik – IMTEK, Albert-Ludwigs-Universität Freiburg (Since 10.2023)
Researching network development and spatial embedding of inhibitory neurons.

Research Associate
Institute of Anatomy and Cell Biology, University of Ulm (01.2022 – 03.2023)
Investigated synaptic aging in Alzheimer’s and ALS; led tutoring and scientific discussions.

Research Assistant
Institute of Anatomy and Cell Biology, University of Ulm (01.2021 – 04.2021)
Assisted in experiments, maintained research records, and implemented data analysis software.

Training and Internship
Center for Clinical Research, University Clinic for Neurology, Ulm (10.2020 – 11.2020)
Studied clinical drug development and principles of pharmacokinetics.

Student Research Intern
Institute for Physiological Chemistry, University of Ulm (08.2020 – 10.2020)
Analyzed mouse models for NF kappa B expression and receptor tyrosine kinase investigation.

📚 Certifications

FELASA – Laboratory Animal Science Course (11.2023)
Project Management by IGradU (02.2023)
Scientific Writing and Presentation Skills (IGradU, 2022)
Writing in the Sciences by Stanford (07.2021)
Drug Discovery and Development by UC San Diego (12.2020)

🏆 Awards

STIBET Scholarship by Ulm University and DAAD (2020 – 2021)

🔧 Skills

Cell culture techniques, qPCR, Western Blot, Immunocytochemistry
Data analysis software including MATLAB, GraphPad Prism, ImageJ

Publications

Current status of drug targets and emerging therapeutic strategies in the management of Alzheimer’s disease
  • Authors: Shampa Ghosh, Shantanu Durgvanshi, Shreya Agarwal, Manchala Raghunath, Jitendra K Sinha
  • Journal: Current neuropharmacology
  • Year: 2020
Long-Term Potentiation
  • Authors: Jitendra Kumar Sinha, Shreya Agarwal, Shampa Ghosh
  • Year: 2022
Pituitary Gland
  • Authors: S Ghosh, S Durgvanshi, S Agarwal, JK Sinha
  • Journal: Encyclopedia of Animal Cognition and Behavior
  • Year: 2019